Literature DB >> 32108284

Proton Beam Therapy in Liver Malignancies.

Osman Siddiqui1, Ariel Pollock1, Santanu Samanta1, Adeel Kaiser2, Jason K Molitoris3.   

Abstract

PURPOSE OF REVIEW: Proton beam therapy (PBT) allows for improved sparing of surrounding normal tissues compared with X-ray-based radiation therapy. This is especially important in the setting of liver malignancies, where an increase in integral dose leads to a higher risk of radiation-induced liver disease (RILD) as well as close proximity to vital gastrointestinal (GI) organs. RECENT
FINDINGS: We have data from multiple centers demonstrating that PBT can safely deliver high, ablative doses of radiation therapy conferring excellent local control with good tolerance of treatment. PBT is an effective treatment with longstanding evidence of efficacy that is increasing in availability.

Entities:  

Keywords:  Hepatocellular carcinoma (HCC); Intrahepatic cholangiocarcinoma (IHC); Liver metastases; Proton beam therapy (PBT); Radiation

Mesh:

Year:  2020        PMID: 32108284     DOI: 10.1007/s11912-020-0889-9

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  26 in total

1.  Proton beam therapy outcomes for localized unresectable hepatocellular carcinoma.

Authors:  Awalpreet S Chadha; Jillian R Gunther; Cheng-En Hsieh; Maureen Aliru; Lakshmi S Mahadevan; Bhanu P Venkatesulu; Christopher H Crane; Prajnan Das; Joseph M Herman; Eugene J Koay; Cullen Taniguchi; Emma B Holliday; Bruce D Minsky; Yelin Suh; Peter Park; Gabriel Sawakuchi; Sam Beddar; Bruno C Odisio; Sanjay Gupta; Evelyne Loyer; Harmeet Kaur; Kanwal Raghav; Milind M Javle; Ahmed O Kaseb; Sunil Krishnan
Journal:  Radiother Oncol       Date:  2019-01-16       Impact factor: 6.280

Review 2.  Proton beam radiation as salvage therapy for bilateral colorectal liver metastases not amenable to second-stage hepatectomy.

Authors:  Lauren E Colbert; Jordan M Cloyd; Eugene J Koay; Christopher H Crane; Jean-Nicolas Vauthey
Journal:  Surgery       Date:  2017-01-09       Impact factor: 3.982

Review 3.  Treatment planning optimisation in proton therapy.

Authors:  S E McGowan; N G Burnet; A J Lomax
Journal:  Br J Radiol       Date:  2013-01       Impact factor: 3.039

4.  Analysis of repeated proton beam therapy for patients with hepatocellular carcinoma.

Authors:  Yoshiko Oshiro; Masashi Mizumoto; Toshiyuki Okumura; Kuniaki Fukuda; Nobuyoshi Fukumitsu; Masato Abei; Hitoshi Ishikawa; Daichi Takizawa; Hideyuki Sakurai
Journal:  Radiother Oncol       Date:  2017-03-30       Impact factor: 6.280

5.  Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma.

Authors:  Alexis Bujold; Christine A Massey; John J Kim; James Brierley; Charles Cho; Rebecca K S Wong; Rob E Dinniwell; Zahra Kassam; Jolie Ringash; Bernard Cummings; Jenna Sykes; Morris Sherman; Jennifer J Knox; Laura A Dawson
Journal:  J Clin Oncol       Date:  2013-04-01       Impact factor: 44.544

6.  Stereotactic radiotherapy of primary liver cancer and hepatic metastases.

Authors:  Joern Wulf; Matthias Guckenberger; Ulrich Haedinger; Ulrich Oppitz; Gerd Mueller; Kurt Baier; Michael Flentje
Journal:  Acta Oncol       Date:  2006       Impact factor: 4.089

7.  Predictors of Radiation-Induced Liver Disease in Eastern and Western Patients With Hepatocellular Carcinoma Undergoing Proton Beam Therapy.

Authors:  Cheng-En Hsieh; Bhanu Prasad Venkatesulu; Ching-Hsin Lee; Sheng-Ping Hung; Pei-Fong Wong; Sathvik Panambur Aithala; Byung Kyu Kim; Arvind Rao; Joseph Tung-Chieh Chang; Ngan-Ming Tsang; Chun-Chieh Wang; Chung-Chi Lee; Chen-Chun Lin; Jeng-Hwei Tseng; Wen-Chi Chou; Yu-Chao Wang; Sunil Krishnan; Ji-Hong Hong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-02-21       Impact factor: 7.038

8.  Stereotactic body radiotherapy for unresectable cholangiocarcinoma.

Authors:  Neil Kopek; Marianne Ingerslev Holt; Anders Traberg Hansen; Morten Høyer
Journal:  Radiother Oncol       Date:  2009-12-04       Impact factor: 6.280

9.  Proton beam therapy for liver metastases from gastric cancer.

Authors:  Nobuyoshi Fukumitsu; Toshiyuki Okumura; Daichi Takizawa; Haruko Numajiri; Kayoko Ohnishi; Masashi Mizumoto; Teruhito Aihara; Hitoshi Ishikawa; Koji Tsuboi; Hideyuki Sakurai
Journal:  J Radiat Res       Date:  2017-05-01       Impact factor: 2.724

10.  Clinical outcomes and toxicity of proton beam therapy for advanced cholangiocarcinoma.

Authors:  Chiyoko Makita; Tatsuya Nakamura; Akinori Takada; Kanako Takayama; Motohisa Suzuki; Yojiro Ishikawa; Yusuke Azami; Takahiro Kato; Iwao Tsukiyama; Yasuhiro Kikuchi; Masato Hareyama; Masao Murakami; Nobukazu Fuwa; Masaharu Hata; Tomio Inoue
Journal:  Radiat Oncol       Date:  2014-01-14       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.